Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1)

Bioorganic & Medicinal Chemistry Letters
Michael G OrchardMartin Page

Abstract

The first inhibitors of fungal protein: mannosyl transferase 1 (PMT1) are described. They are based upon rhodanine-3-acetic acid and several compounds have been identified, for example, 5-[[3-(1-phenylethoxy)-4-(2-phenylethoxy)phenyl]methylene]-4-oxo-2-thioxo-3-thiazolidineacetic acid (5a), which inhibit Candida albicans PMT1 with IC(50)s in the range 0.2-0.5 microM. Members of the series are effective in inducing changes in morphology of C. albicans in vitro that have previously been associated with loss of the transferase activity. These compounds could serve as useful tools for studying the effects of protein O-mannosylation and its relevance in the search for novel antifungal agents.

References

Mar 20, 1999·The Journal of Biological Chemistry·S Strahl-Bolsinger, A Scheinost
Apr 15, 2000·The Journal of Biological Chemistry·V GirrbachS Strahl-Bolsinger

❮ Previous
Next ❯

Citations

Jun 30, 2010·Applied Microbiology and Biotechnology·Karen De PourcqNico Callewaert
Mar 20, 2009·Nature Chemical Biology·Jamie R Rich, Stephen G Withers
Feb 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·Koh AmanoHisashi Narimatsu
Sep 29, 2006·Antimicrobial Agents and Chemotherapy·Heidrun Peltroche-LlacsahuangaJoachim F Ernst
Nov 28, 2007·Applied and Environmental Microbiology·Kousuke KurodaYoshifumi Jigami
Mar 8, 2008·Bioscience, Biotechnology, and Biochemistry·Yoshifumi Jigami
Jul 28, 2009·PloS One·Sven D WillgerKlaus B Lengeler
Jul 11, 2013·PloS One·Juergen H NettStephen R Hamilton
Feb 10, 2012·PLoS Pathogens·Eva Szafranski-SchneiderJoachim F Ernst
Jan 1, 2013·International Journal of Medicinal Chemistry·Ravinder Singh BhattiJagir S Sandhu
Feb 15, 2014·Applied Microbiology and Biotechnology·Sujatha Gomathinayagam, Stephen R Hamilton
Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Mark LommelSabine Strahl
Jun 13, 2012·The Journal of Cell Biology·Eric M RubensteinMark Hochstrasser
Aug 8, 2015·Cellular and Molecular Life Sciences : CMLS·E RagniL Lazzari
Jan 19, 2011·Expert Opinion on Therapeutic Patents·Chiara CalugiAntonio Guarna
Nov 11, 2014·Applied Microbiology and Biotechnology·Daniel HopkinsStephen R Hamilton
Jan 20, 2015·Future Microbiology·Bram LaukensNico Callewaert
Mar 31, 2017·Journal of Bioscience and Bioengineering·Takeshi SuzukiYasunori Chiba
Jun 10, 2017·International Journal of Molecular Sciences·Ewa ZatorskaSabine Strahl
Jul 12, 2014·Current Opinion in Biotechnology·Michael A Meehl, Terrance A Stadheim
Oct 12, 2017·Expert Opinion on Drug Discovery·Danylo KaminskyyRoman Lesyk
Feb 3, 2015·Organic & Biomolecular Chemistry·M KamlarJ Veselý
May 16, 2007·Molecular Microbiology·Pilar D CanteroJoachim F Ernst
Jul 31, 2010·Chembiochem : a European Journal of Chemical Biology·Gerd K Wagner, Thomas Pesnot
Apr 10, 2010·Expert Review of Anti-infective Therapy·Vishukumar Aimanianda, Jean-Paul Latgé
Nov 30, 2019·Expert Opinion on Drug Discovery·Suresh MaddilaSreekantha B Jonnalagadda
Jan 15, 2011·Molecular Microbiology·Javier ArroyoSabine Strahl
May 15, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alberto InsuastyBraulio Insuasty
Feb 13, 2016·Acta Crystallographica. Section E, Crystallographic Communications·Rahhal El AjlaouiLahcen El Ammari
Aug 3, 2016·Cold Spring Harbor Protocols·Hiroki OkadaYoshikazu Ohya
Oct 11, 2020·Chemico-biological Interactions·Marta Kucerova-ChlupacovaMarta Soltesova Prnova
Jun 11, 2010·Journal of Combinatorial Chemistry·Young-Dae Gong, Taeho Lee
Aug 26, 2006·Chemistry & Biology·Erin E CarlsonLaura L Kiessling
Jul 14, 2011·Chemical Reviews·Ryan M SchmaltzChi-Huey Wong
Sep 7, 2007·Organic Letters·Sandra GabilletFrédéric Taran
Nov 20, 2021·International Journal of Antimicrobial Agents·Chibuike IbeOmran Alamir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.